These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Lang BH; Lo CY; Chan WF; Lam KY; Wan KY Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065 [TBL] [Abstract][Full Text] [Related]
12. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy. Mitrofanova E; Unfer R; Vahanian N; Link C Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. Perros P J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer. Chen PV; Osborne R; Ahn E; Avitia S; Juillard G Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160 [TBL] [Abstract][Full Text] [Related]
16. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid]. Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038 [TBL] [Abstract][Full Text] [Related]
17. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Schlumberger M; Lacroix L; Russo D; Filetti S; Bidart JM Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):260-9. PubMed ID: 17315034 [TBL] [Abstract][Full Text] [Related]
18. [Stimulation of adenyl cyclase and fixation of iodine in human cancerous thyroid cells in culture]. Thomas-Morvan C C R Acad Sci III; 1985; 301(10):487-90. PubMed ID: 3004675 [TBL] [Abstract][Full Text] [Related]
19. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer]. Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697 [No Abstract] [Full Text] [Related]
20. Management of follicular and Hürthle cell neoplasms of the thyroid gland. McHenry CR; Sandoval BA Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]